GLP-1 listings in FDA’s NDC Directory

Which companies list semaglutide, tirzepatide or liraglutide products in FDA’s NDC Directory?

FDA’s NDC Directory files, read Nov 15, 2026, carry 467 product listings naming semaglutide, tirzepatide, liraglutide, retatrutide or cagrilintide. 75 listings from 19 outsourcing facilities carry the category “OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)”, 214 listings are bulk ingredients, and 101 listings are finished drugs under an NDA, ANDA or BLA. FDA says assignment of an NDC number “does not in any way denote FDA approval of the product.”

FDA’s own words on the NDC Directory page (content current as of Mar 4, 2026):

Inclusion in the NDC Directory does not indicate that FDA has verified the information provided or that the products are FDA-approved. The content of each NDC Directory entry is the responsibility of the labeler submitting the SPL file. Assignment of an NDC number does not in any way denote FDA approval of the product. Any representation that creates an impression of FDA approval because a product has an NDC number is misleading and violates federal law. Inclusion in the NDC Directory or assignment of an NDC number does not mean a product is a drug as defined by federal law.

Answer pages: Which outsourcing facilities list compounded semaglutide or tirzepatide with FDA?, Is a listed NDC number the same as FDA approval? FDA’s own words, Which companies list bulk semaglutide or tirzepatide ingredient with FDA?.

Listings by marketing category and drug

Marketing categories are FDA’s, verbatim. A listing that names two tracked drugs counts under each.

BULK INGREDIENT564634101147
NDA325450091
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)383340075
DRUG FOR FURTHER PROCESSING274200069
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING352651067
ANDA00150015
NDA AUTHORIZED GENERIC002002
BLA001001

Outsourcing facility compounded listings

75 products in FDA’s compounded drugs file carry the category “OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)”. FDA’s file gives reporting periods, not marketing dates.

Reporting periods
54288-846BPI Labs LLCLiraglutide Injection, 18 mg/3 mL (6 mg/mL)Liraglutide Injection, 18 mg/3 mL (6 mg/mL)INJECTIONSUBCUTANEOUS18 mg/3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
73198-151Olympia PharmacyLiraglutide 6 mg/mLLiraglutide 6mg/mLINJECTION, SOLUTIONSUBCUTANEOUS6 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
81375-606PQ Pharmacy LLCLiraglutideLiraglutideINJECTIONSUBCUTANEOUS6 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2
81375-614PQ Pharmacy LLCLiraglutideLiraglutideINJECTIONSUBCUTANEOUS15 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2
82396-300ANNOVEX PHARMA, INC.SemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
82396-302ANNOVEX PHARMA, INC.SemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
82396-305ANNOVEX PHARMA, INC.SemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
71170-495Apollo Care, LLCSemaglutide 12.5 mgSemaglutide 12.5 mgINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
71170-640Apollo Care, LLCSemaglutide 1mg and Cyanocobalamin 0.5mgSemaglutide 1mg and Cyanocobalamin 0.5mgINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mL; .5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2
71170-650Apollo Care, LLCSemaglutide 2.5mg and Cyanocobalamin 0.5mgSemaglutide 2.5mg and Cyanocobalamin 0.5mgINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mL; .5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2
71170-690Apollo Care, LLCSemaglutide 12.5mg and Cyanocobalamin 2.5mgSemaglutide 12.5mg and Cyanocobalamin 2.5mgINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mL; .5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2
71170-811Apollo Care, LLCSemaglutide 2.25 mgSemaglutide 2.25 mgINJECTION, SOLUTIONSUBCUTANEOUS.9 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
71170-821Apollo Care, LLCSemaglutide 6.75 mgSemaglutide 6.75 mgINJECTION, SOLUTIONSUBCUTANEOUS4.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
54288-826BPI Labs LLCSemaglutide Injection, 1 mg/mLSemaglutide Injection, 1 mg/mLINJECTIONSUBCUTANEOUS1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-827BPI Labs LLCSemaglutide Injection, 5 mg/2 mL (2.5 mg/mL)Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL)INJECTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-831BPI Labs LLCSemaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL)Semaglutide Injection, 12.5 mg/2.5 mL (5 mg/mL)INJECTIONSUBCUTANEOUS12.5 mg/2.5 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-833BPI Labs LLCSemaglutide Injection, 2.5mg/mL (1mL vial)Semaglutide Injection, 2.5mg/mL (1mL vial)INJECTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
71791-0200Delta Pharma INCSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
69852-417Eagle Pharma Outsourcing, LLCSemaglutide 1 mg/mLSemaglutide 1 mg/mLINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mgOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
69852-517Eagle Pharma Outsourcing, LLCSemaglutide 2.4 mg/mLSemaglutide 2.4 mg/mLINJECTION, SOLUTIONSUBCUTANEOUS2.4 mg/2.4 mgOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
72627-2321Empower PharmaSemaglutide/CyanocobalaminSemaglutide/CyanocobalaminINJECTIONSUBCUTANEOUS.5 mg/1 mL; 1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
72627-2322Empower PharmaSemaglutide/CyanocobalaminSemaglutide/CyanocobalaminINJECTIONSUBCUTANEOUS5 mg/1 mL; .5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
71266-6100Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB LaboratoriesSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
71266-6110Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB LaboratoriesSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
26436-5608Hybrid PharmaSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1, 2026-1
26436-5635Hybrid PharmaSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1, 2026-1
70657-1027MedisourceRxSemaglutideSemaglutideSOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
73013-9000OurPharma LLCSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
73013-9001OurPharma LLCSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
73013-9002OurPharma LLCSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
81375-600PQ Pharmacy LLCSemaglutideSemaglutide 2.5mg/mLINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81375-601PQ Pharmacy LLCSemaglutideSemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81375-605PQ Pharmacy LLCSemaglutideSemaglutide 5mg/mLINJECTION, SOLUTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
84582-4104Signature RxSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS4 mg/3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
81483-0045Tailstorm Health INCSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS.25 mg/.05 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0046Tailstorm Health INCSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS.5 mg/.1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0047Tailstorm Health INCSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS1 mg/.2 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0048Tailstorm Health INCSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS1.7 mg/.22 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0049Tailstorm Health INCSEMAGLUTIDESEMAGLUTIDEINJECTIONSUBCUTANEOUS2.4 mg/.3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
83556-0201Turbare ManufacturingSemaglutide 1 mg/mLSemaglutide 1 mg/mLINJECTION, SOLUTIONSUBCUTANEOUS1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
83556-0205Turbare ManufacturingSemaglutide 5 mg/mLSemaglutide 5 mg/mLINJECTION, SOLUTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
73702-197Wells Pharma of HoustonSemaglutideSemaglutide injectionINJECTIONINTRAMUSCULAR2.5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
72682-1205AnazaoHealth CorporationTirzepatide 5mg/mL 2mLTirzepatide 5mg/mL Injection 2mLINJECTIONSUBCUTANEOUS5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
72682-1220AnazaoHealth CorporationTirzepatide 20mg/mL 2mLTirzepatide 20mg/mL 2mLINJECTIONSUBCUTANEOUS20 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
82396-350ANNOVEX PHARMA, INC.TirzepatideTirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
82396-351ANNOVEX PHARMA, INC.TirzepatideTirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
71170-610Apollo Care, LLCTirzepatide 20mg and Pyridoxine 8mgTirzepatide 20mg and Pyridoxine 8mgINJECTION, SOLUTIONSUBCUTANEOUS10 mg/1 mL; 4 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2
71170-630Apollo Care, LLCTirzepatide 60mg and Pyridoxine 12mgTirzepatide 60mg and Pyridoxine 12mgINJECTION, SOLUTIONSUBCUTANEOUS20 mg/1 mL; 4 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2
85091-001Apothecary Pharma LLCTirzepatideTirzepatide InjectionINJECTION, SOLUTIONSUBCUTANEOUS18 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
85091-003Apothecary Pharma LLCTirzepatideTirzepatide InjectionINJECTION, SOLUTIONSUBCUTANEOUS9 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
85091-004Apothecary Pharma LLCTirzepatide and B12Tirzepatide InjectionINJECTION, SOLUTIONSUBCUTANEOUS17 mg/1 mL; 1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
85091-005Apothecary Pharma LLCTirzepatide and B12Tirzepatide InjectionINJECTION, SOLUTIONSUBCUTANEOUS8.5 mg/1 mL; 1 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
85091-006Apothecary Pharma LLCTirzepatide and GlycineTirzepatide InjectionINJECTION, SOLUTIONSUBCUTANEOUS17 mg/1 mL; 5 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
54288-832BPI Labs LLCTirzepatide Injection, 30 mg/3 mLTirzepatide Injection, 30 mg/3 mLINJECTIONSUBCUTANEOUS10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-835BPI Labs LLCTirzepatide Injection, 10 mg/mLTirzepatide Injection, 10 mg/mLINJECTIONSUBCUTANEOUS10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-836BPI Labs LLCTirzepatide Injection, 60 mg/3 mLTirzepatide Injection, 60 mg/3 mLINJECTIONSUBCUTANEOUS20 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
54288-840BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 30 mg/3 mL (10 mg/mL) and 30 mg/3 mL (10 mg/mL)Tirzepatide and Pyridoxine Hydrochloride Injection, 30 mg/3 mL (10 mg/mL) and 30 mg/3 mL (10 mg/mL)INJECTIONSUBCUTANEOUS30 mg/3 mL; 30 mg/3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
54288-841BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 10 mg/mL and 10 mg/mLTirzepatide and Pyridoxine Hydrochloride Injection, 10 mg/mL and 10 mg/mLINJECTIONSUBCUTANEOUS10 mg/1 mL; 10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
54288-842BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 60 mg/3 mL (20 mg/mL) and 30 mg/3 mL (10 mg/mL)Tirzepatide and Pyridoxine Hydrochloride Injection, 60 mg/3 mL (20 mg/mL) and 30 mg/3 mL (10 mg/mL)INJECTIONSUBCUTANEOUS30 mg/3 mL; 60 mg/3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
54288-848BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 40 mg/4 mL (10 mg/mL) and 40 mg/4 mL (10 mg/mL)Tirzepatide and Pyridoxine Hydrochloride Injection, 40 mg/4 mL (10 mg/mL) and 40 mg/4 mL (10 mg/mL)INJECTIONSUBCUTANEOUS40 mg/4 mL; 40 mg/4 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-2, 2026-1
54288-859BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 20 mg/2 mL (10 mg/mL) and 20 mg/2 mL (10 mg/mL)Tirzepatide and Pyridoxine Hydrochloride Injection, 20 mg/2 mL (10 mg/mL) and 20 mg/2 mL (10 mg/mL)INJECTIONSUBCUTANEOUS20 mg/2 mL; 20 mg/2 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
54288-860BPI Labs LLCTirzepatide and Pyridoxine Hydrochloride Injection, 68 mg/4 mL (17 mg/mL) and 40 mg/4 mL (10 mg/mL)Tirzepatide and Pyridoxine Hydrochloride Injection, 68 mg/4 mL (17 mg/mL) and 40 mg/4 mL (10 mg/mL)INJECTIONSUBCUTANEOUS68 mg/4 mL; 40 mg/4 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
72627-2323Empower PharmaTirzepatide/NiacinamideTirzepatide/NiacinamideINJECTIONSUBCUTANEOUS8 mg/1 mL; 2 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
72627-2324Empower PharmaTirzepatide/NiacinamideTirzepatide/NiacinamideINJECTIONSUBCUTANEOUS2 mg/1 mL; 17 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1
26436-5622Hybrid PharmaTIRZEPATIDE 10MG/MLTIRZEPATIDE 10MG/MLINJECTION, SOLUTIONSUBCUTANEOUS10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1, 2025-2, 2026-1
26436-5636Hybrid PharmaTIRZEPATIDE 20MG/MLTIRZEPATIDE 20MG/MLINJECTION, SOLUTIONSUBCUTANEOUS20 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2025-1, 2025-2, 2026-1
85049-420PGRrx LLCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS17 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2026-1
81375-610PQ Pharmacy LLCTirzepatideTirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81375-620PQ Pharmacy LLCTirzepatideTirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20 mg/1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0050Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS2.4 mg/.1 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0051Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS5 mg/.2 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0052Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS7.5 mg/.3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0053Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS10 mg/.2 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0054Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS12.5 mg/.25 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1
81483-0055Tailstorm Health INCTirzepatideTirzepatideINJECTIONSUBCUTANEOUS15 mg/.3 mLOUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)2024-2, 2025-1

Labelers

One row per labeler name, grouped by exact name. A labeler links to its page here when one exists under the same name, or to its own NDC page when it has 2 or more compounded or bulk listings and no other page.

Marketing categoriesDrugsPage here
A-S Medication Solutions17NDA (15); ANDA (1); NDA AUTHORIZED GENERIC (1)Liraglutide, Semaglutide, TirzepatideNDA, ANDA or BLA listings only
AnazaoHealth Corporation2OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (2)Tirzepatide503B facility: AnazaoHealth Corporation, Las Vegas, NV
Pharmacy: AnazaoHealth Corporation, Las Vegas, NV
ANNOVEX PHARMA, INC.5OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (5)Semaglutide, Tirzepatide503B facility: Annovex Pharma, Inc., Lorton, VA
Pharmacy: Annovex Pharma, Inc., Lorton, VA
Apicore Pharmaceuticals private Limited; Apicore Pharmaceuticals Private Limited2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Apollo Care, LLC8OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (8)Semaglutide, Tirzepatide503B facility: Apollo Care, Columbia, MO
Pharmacy: Apollo Care, Columbia, MO

Pharmacy: Apollo Care LLC, Columbia, MO

Company: Apollo Care, LLC
Apothecary Pharma LLC5OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (5)Tirzepatide503B facility: Apothecary Pharma, LLC, Cary, NC
Pharmacy: Apothecary Pharma, LLC, Cary, NC

Company: Apothecary Pharma LLC
Arene Life Sciences Private Limited1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Assia Chemical Industries Ltd. - Teva Tech Site1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
Aurisco Pharmaceutical Co.,Ltd19BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (17); BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Aurobindo Pharma Limited1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Bachem AG1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Bachem Americas, Inc.1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Bills Biotech Pvt. Ltd.1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Biocon Limited; BIOCON LIMITED3BULK INGREDIENT (3)Liraglutide, Semaglutide, TirzepatideNDC labeler page
Biocon Pharma Inc.2ANDA (2)LiraglutideNDA, ANDA or BLA listings only
BioVectra Inc.1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
BPI Labs LLC14OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (14)Liraglutide, Semaglutide, Tirzepatide503B facility: BPI Labs LLC, Largo, FL
Pharmacy: BPI Labs LLC, Largo, FL
BSP Pharmaceuticals SpA12DRUG FOR FURTHER PROCESSING (12)TirzepatideFurther-processing listings only
Catalent Indiana, LLC2DRUG FOR FURTHER PROCESSING (2)SemaglutideFurther-processing listings only
Chatnaa Life Sciences LLC2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Chengdu Brilliant Biopharmaceutical Co., Ltd.1BULK INGREDIENT (1)SemaglutideCompany: Chengdu Brilliant Biopharmaceutical Co., Ltd.
Chengdu Shengnuo Biopharm Co. Ltd.; Chengdu Shengnuo Biopharm Co., Ltd.8BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (5); BULK INGREDIENT (3)Liraglutide, Semaglutide, TirzepatideNDC labeler page
Chinese Peptide Company1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Chongqing Sintaho Pharmaceutical Co., Ltd.2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Chunghwa Chemical Synthesis & Biotech Co., Ltd.1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Cipla USA Inc.2ANDA (2)LiraglutideNDA, ANDA or BLA listings only
Corden Pharma Colorado, Inc.1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
DARMERICA, LLC3BULK INGREDIENT (3)Liraglutide, Semaglutide, TirzepatideCompany: Darmerica, LLC
Delta Pharma INC1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)Semaglutide503B facility: Delta Pharma, Inc., Ripley, MS
Pharmacy: Delta Pharma, Inc., Ripley, MS
Dr. Reddy's Laboratories Limited; Dr. Reddy’s Laboratories Limited2BULK INGREDIENT (2)Liraglutide, SemaglutideNDC labeler page
Eagle Pharma Outsourcing, LLC2OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (2)SemaglutideNDC labeler page
El-Peptido (Shanghai) Biopharmaceutical Co., Ltd2BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Semaglutide, TirzepatideNDC labeler page
Eli Lilly and Company49NDA (48); BULK INGREDIENT (1)TirzepatideBrand originator; listed, not paged
Eli Lilly Italia SPA12DRUG FOR FURTHER PROCESSING (12)TirzepatideBrand originator; listed, not paged
Empower Pharma4OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (4)Semaglutide, Tirzepatide503B facility: Empower Pharma, Houston, TX
Pharmacy: Empower Pharma, Houston, TX
ETERNAL WEALTH(CHINA)LIMITED2BULK INGREDIENT (2)Liraglutide, RetatrutideNDC labeler page
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories2OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (2)Semaglutide503B facility: Fagron Compounding Services dba Fagron Sterile Services, Wichita, KS
Pharmacy: Fagron Compounding Services dba Fagron Sterile Services, Wichita, KS

Pharmacy: Fagron Sterile Services (Fagron Compounding Services LLC), Wichita, KS

Pharmacy: JCB Laboratories, LLC, Wichita, KS
FRESENIUS KABI IPSUM SRL1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Fujian Genohope Biotech Ltd.5BULK INGREDIENT (5)Liraglutide, Semaglutide, TirzepatideAPI supplier: Fujian Genohope Biotech Ltd
Guangdong Longfu Medicine Co., Ltd.1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
Hainan Poly Pharm. Co., Ltd.1BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (1)SemaglutideOne compounded or bulk listing
Hangzhou Hotide Biotech Co.,Ltd1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
Harbin Jixianglong Biotech Co., Ltd.2BULK INGREDIENT (2)Retatrutide, TirzepatideCompany: Harbin Jixianglong Biotech Co., Ltd.
API supplier: Harbin Jixianglong Biotech Co., Ltd.
HETERO DRUGS LIMITED1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Hikma Pharmaceuticals USA Inc.1ANDA (1)LiraglutidePharmacy: Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
Hubei JXBio Pharmaceutical Co.,Ltd; Hubei JXBio Pharmaceutical Co., Ltd4BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (3); BULK INGREDIENT (1)Liraglutide, Semaglutide, TirzepatideAPI supplier: Hubei JXBio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd.; Hybio Pharmaceutical Co. Ltd; Hybio Pharmaceutical Co., Ltd46BULK INGREDIENT (26); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (20)Liraglutide, Semaglutide, TirzepatideAPI supplier: Hybio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)24BULK INGREDIENT (21); ANDA (3)Liraglutide, Retatrutide, Semaglutide, TirzepatideNDC labeler page
Hybrid Pharma4OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (4)Semaglutide, Tirzepatide503B facility: Hybrid Pharma, LLC, Deerfield Beach, CA
Pharmacy: Hybrid Pharma, LLC, Deerfield Beach, CA

Pharmacy: Hybrid Pharma LLC, Deerfield Beach, FL
Jilin Qijian Bio-Pharmaceutical Co., Ltd.1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Lupin Pharmaceuticals, Inc.1ANDA (1)LiraglutideNDA, ANDA or BLA listings only
Medisca Inc.2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
MedisourceRx1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)Semaglutide503B facility: MedisourceRx, Los Alamitos, CA
Pharmacy: MedisourceRx, Los Alamitos, CA
Meitheal Pharmaceuticals Inc.1ANDA (1)LiraglutideNDA, ANDA or BLA listings only
MSN Life Sciences Private Limited3BULK INGREDIENT (3)Liraglutide, Semaglutide, TirzepatideNDC labeler page
Nanjing Xingyin Pharmaceutical Group Co.,Ltd1BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (1)LiraglutideOne compounded or bulk listing
NOMIDA LLC; Nomida LLC3BULK INGREDIENT (3)Liraglutide, Semaglutide, TirzepatideNDC labeler page
NorthStar Rx LLC1ANDA (1)LiraglutideNDA, ANDA or BLA listings only
Novo Nordisk2BLA (1); NDA (1)LiraglutideBrand originator; listed, not paged
Novo Nordisk A/S13DRUG FOR FURTHER PROCESSING (10); BULK INGREDIENT (3)Liraglutide, SemaglutideBrand originator; listed, not paged
Novo Nordisk Pharmaceutical Industries, LP26NDA (26)Liraglutide, SemaglutideBrand originator; listed, not paged
Novo Nordisk Production Belgium SA10DRUG FOR FURTHER PROCESSING (10)SemaglutideBrand originator; listed, not paged
Olympia Pharmacy1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)LiraglutidePharmacy: Olympia Pharmacy (OPS International, Inc.), Orlando, FL
Orbicular Pharmaceutical Technologies Private Limited2ANDA (2)LiraglutideNDA, ANDA or BLA listings only
OurPharma LLC3OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (3)Semaglutide503B facility: OurPharma LLC, Fayetteville, AR
Pharmacy: OurPharma LLC, Fayetteville, AR
Patheon Manufacturing Services LLC5DRUG FOR FURTHER PROCESSING (5)SemaglutideFurther-processing listings only
PGRrx LLC1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)Tirzepatide503B facility: PGRrx LLC, Exton, PA
Pharmacy: PGRrx LLC, Exton, PA
Pharma Source Direct, Inc.2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Polypeptide Laboratories Inc1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
PolyPeptide SA1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
PQ Pharmacy LLC7OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (7)Liraglutide, Semaglutide, Tirzepatide503B facility: PQ Pharmacy LLC, Brooksville, FL
Pharmacy: PQ Pharmacy LLC, Brooksville, FL

Company: PQ Pharmacy, LLC
REMEDYREPACK INC.1NDA (1)SemaglutideNDA, ANDA or BLA listings only
Resilience US, LLC18DRUG FOR FURTHER PROCESSING (18)TirzepatideFurther-processing listings only
SCH Global Services Private Limited1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
ScinoPharm Taiwan Ltd.1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Shanghai Ambiopharm, Inc2BULK INGREDIENT (2)Liraglutide, SemaglutideNDC labeler page
Shanghai SynTheAll Pharmaceutical Co., Ltd.2BULK INGREDIENT (1); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (1)Retatrutide, TirzepatideNDC labeler page
Shenzhen Alvantis Pharma Co., Ltd.4BULK INGREDIENT (2); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Cagrilintide, Retatrutide, Semaglutide, TirzepatideNDC labeler page
SHILPA PHARMA LIFESCIENCES LIMITED2BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Liraglutide, SemaglutideNDC labeler page
Sichuan Jisheng Biopharmaceutical Co Ltd2BULK INGREDIENT (2)Semaglutide, TirzepatideNDC labeler page
Signature Rx1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)Semaglutide503B facility: Signature Rx, Delray Beach, FL
Pharmacy: Signature Rx, Delray Beach, FL
Sinopep-Allsino Biopharmaceutical Co., Ltd.; Sinopep-Allsino Biopharmaceutical Co.,Ltd.10BULK INGREDIENT (6); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (4)Liraglutide, Retatrutide, Semaglutide, TirzepatideNDC labeler page
SUN PHARMACEUTICAL INDUSTRIES, INC.1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Supriya Lifescience Limited1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Suzhou Lixin Pharmaceutical Co., Ltd.2BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Semaglutide, TirzepatideNDC labeler page
Suzhou Tianma Pharma Group Co., Ltd.1BULK INGREDIENT (1)TirzepatideOne compounded or bulk listing
Tailstorm Health INC11OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (11)Semaglutide, Tirzepatide503B facility: Tailstorm Health Inc., Chandler, AZ
Pharmacy: Tailstorm Health Inc., Chandler, AZ

Pharmacy: Tailstorm Health, Inc., Phoenix, AZ

Company: Tailstorm Health Inc. dba Medivant Health
Teva Pharmaceuticals USA, Inc.1NDA AUTHORIZED GENERIC (1)LiraglutideNDA, ANDA or BLA listings only
Teva Pharmaceuticals, Inc.1ANDA (1)LiraglutideNDA, ANDA or BLA listings only
Thaeta Scientific LLC2BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Semaglutide, TirzepatideNDC labeler page
Tonghua Dongbao Pharmaceutical Co., Ltd1BULK INGREDIENT (1)LiraglutideOne compounded or bulk listing
Turbare Manufacturing2OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (2)Semaglutide503B facility: Turbare Manufacturing, Conway, AR
Pharmacy: Turbare Manufacturing, Conway, AR
Virtu Pharmako (Zhejiang) Co., Ltd.6BULK INGREDIENT (6)SemaglutideNDC labeler page
Wells Pharma of Houston1OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (1)Semaglutide503B facility: Wells Pharma of Houston, LLC, Houston, TX
Pharmacy: Wells Pharma of Houston, LLC, Houston, TX
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing
Zhejiang Kingland Pharmaceutical Company Limited10BULK INGREDIENT (10)Semaglutide, TirzepatideNDC labeler page
Zhejiang Peptites Biotech Co., Ltd.; Zhejiang Peptites Biotech Co., Ltd3BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (3)Liraglutide, Semaglutide, TirzepatideAPI supplier: Zhejiang Peptites Biotech Co.,Ltd.
Zhejiang Tasln Biopharma Co., Ltd.4BULK INGREDIENT (2); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (2)Semaglutide, TirzepatideNDC labeler page
Zhuhai Readline Biotech Co., Ltd.1BULK INGREDIENT (1)SemaglutideOne compounded or bulk listing

Bulk ingredient listings

214 listings in FDA’s unfinished drugs file under “BULK INGREDIENT” or “BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING”. A bulk ingredient listing is a labeler’s report of an active ingredient it makes or handles; it is not a finished drug.

84347-007Shenzhen Alvantis Pharma Co., Ltd.Not givenCagrilintidePOWDERNot given1 g/gBULK INGREDIENTFeb 17, 2025None givenDec 31, 2027
59651-772Aurobindo Pharma LimitedNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTDec 28, 2023None givenDec 31, 2026
52416-735Bachem Americas, Inc.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTAug 27, 2025None givenDec 31, 2026
65727-087Biocon LimitedNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTAug 26, 2021None givenDec 31, 2026
32861-0003Chengdu Shengnuo Biopharm Co. Ltd.Not givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTJan 20, 2014None givenDec 31, 2027
71052-126DARMERICA, LLCNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTMay 10, 2023None givenDec 31, 2026
71796-022Dr. Reddy's Laboratories LimitedNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTJun 30, 2020None givenDec 31, 2026
85793-002ETERNAL WEALTH(CHINA)LIMITEDNot givenLiraglutidePOWDERNot given100 g/100gBULK INGREDIENTJun 11, 2025None givenDec 31, 2026
66558-0193FRESENIUS KABI IPSUM SRLNot givenLIRAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENTJun 1, 2021None givenDec 31, 2027
84502-104Fujian Genohope Biotech Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTOct 17, 2024None givenDec 31, 2027
76617-002Hubei JXBio Pharmaceutical Co., LtdNot givenliraglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 14, 2024None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 mg/mgBULK INGREDIENTJun 16, 2025None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 1, 2021None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 1, 2021None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTNov 20, 2024None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 18, 2024None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 18, 2024None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 18, 2024None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 18, 2024None givenDec 31, 2026
14403-0009Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 18, 2024None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 19, 2024None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 19, 2024None givenDec 31, 2026
14403-0021Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTMar 13, 2025None givenDec 31, 2026
69766-034MSN Life Sciences Private LimitedNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTJul 12, 2018None givenDec 31, 2026
70155-003Nanjing Xingyin Pharmaceutical Group Co.,LtdNot givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 12, 2017None givenDec 31, 2026
84223-003NOMIDA LLCNot givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTFeb 1, 2025May 15, 2027Not given
0420-9006Novo Nordisk A/SNot givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTFeb 1, 2011None givenDec 31, 2026
63557-2070Polypeptide Laboratories IncNot givenLIRAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENTJan 1, 2010None givenDec 31, 2026
65129-1375ScinoPharm Taiwan Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTSep 30, 2020None givenDec 31, 2026
41524-0011Shanghai Ambiopharm, IncNot givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2017None givenDec 31, 2027
82920-504SHILPA PHARMA LIFESCIENCES LIMITEDNot givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 30, 2026None givenDec 31, 2027
76177-018Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenLIRAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENTFeb 1, 2019None givenDec 31, 2027
76177-118Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENTMar 1, 2019None givenDec 31, 2026
76177-520Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenLiraglutidePOWDERNot given1 kg/kgBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 1, 2019None givenDec 31, 2026
62756-927SUN PHARMACEUTICAL INDUSTRIES, INC.Not givenLiraglutidePOWDERNot given25 kg/25kgBULK INGREDIENTDec 10, 2025None givenDec 31, 2027
84934-001Tonghua Dongbao Pharmaceutical Co., LtdNot givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENTDec 3, 2024None givenDec 31, 2026
73569-051Zhejiang Peptites Biotech Co., Ltd.Not givenLiraglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 6, 2024None givenDec 31, 2027
85793-001ETERNAL WEALTH(CHINA)LIMITEDNot givenRetatrutidePOWDERNot given100 g/100gBULK INGREDIENTJun 11, 2025None givenDec 31, 2026
84385-103Harbin Jixianglong Biotech Co., Ltd.Not givenRetatrutidePOWDERNot given100 g/100gBULK INGREDIENTJan 9, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
14403-0022Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENTFeb 26, 2025None givenDec 31, 2026
24538-803Shanghai SynTheAll Pharmaceutical Co., Ltd.Not givenRetatrutidePOWDERNot given1 kg/kgBULK INGREDIENTApr 16, 2026None givenDec 31, 2027
84347-003Shenzhen Alvantis Pharma Co., Ltd.Not givenRETATRUTIDEPOWDERNot given1 g/gBULK INGREDIENTFeb 17, 2025None givenDec 31, 2027
76177-055Sinopep-Allsino Biopharmaceutical Co.,Ltd.Not givenRetatrutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 1, 2026None givenDec 31, 2027
42973-397Apicore Pharmaceuticals private LimitedNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTJun 11, 2024None givenDec 31, 2027
71859-010Arene Life Sciences Private LimitedNot givensemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTSep 23, 2026None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTJun 30, 2023None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given5 g/5gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 30, 2023None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 30, 2023None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 30, 2023None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 15, 2025None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given10 g/10gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 15, 2025None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given50 g/50gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 15, 2025None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given20 g/20gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 15, 2025None givenDec 31, 2027
16812-103Aurisco Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTJun 30, 2023None givenDec 31, 2027
55463-0040Bachem AGNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTApr 30, 2024None givenDec 31, 2026
85941-001Bills Biotech Pvt. Ltd.Not givenSemaglutide IHPOWDERNot given100 g/100gBULK INGREDIENTJul 21, 2025None givenDec 31, 2027
65727-094Biocon LimitedNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTSep 17, 2024None givenDec 31, 2026
87181-002Chatnaa Life Sciences LLCNot givenSemaglutidePOWDERNot given1 mg/mgBULK INGREDIENTDec 10, 2025None givenDec 31, 2026
84524-451Chengdu Brilliant Biopharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTAug 23, 2024None givenDec 31, 2026
32861-0011Chengdu Shengnuo Biopharm Co. Ltd.Not givenSemaglutidePOWDERNot given1000 g/1000gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 25, 2024None givenDec 31, 2027
32861-0011Chengdu Shengnuo Biopharm Co. Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 1, 2024None givenDec 31, 2027
32861-0011Chengdu Shengnuo Biopharm Co. Ltd.Not givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTJan 18, 2023None givenDec 31, 2027
32861-0011Chengdu Shengnuo Biopharm Co. Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 1, 2024None givenDec 31, 2027
32861-0014Chengdu Shengnuo Biopharm Co. Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGFeb 1, 2026None givenDec 31, 2027
43963-002Chinese Peptide CompanyNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJul 18, 2023None givenDec 31, 2027
84172-121Chongqing Sintaho Pharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJul 15, 2025None givenDec 31, 2027
52076-6282Chunghwa Chemical Synthesis & Biotech Co., Ltd.Not givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTAug 19, 2024None givenDec 31, 2026
71052-695DARMERICA, LLCNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTApr 25, 2023None givenDec 31, 2027
71796-039Dr. Reddy’s Laboratories LimitedNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTDec 13, 2021None givenDec 31, 2026
87370-005El-Peptido (Shanghai) Biopharmaceutical Co., LtdNot givenSEMAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJan 12, 2026None givenDec 31, 2027
84502-101Fujian Genohope Biotech Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJul 2, 2024None givenDec 31, 2027
84502-109Fujian Genohope Biotech Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTOct 17, 2025None givenDec 31, 2027
84502-113Fujian Genohope Biotech Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTMay 19, 2026None givenDec 31, 2027
14335-790Hainan Poly Pharm. Co., Ltd.Not givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGFeb 28, 2025None givenDec 31, 2027
65977-0165HETERO DRUGS LIMITEDNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTDec 5, 2017None givenDec 31, 2027
76617-001Hubei JXBio Pharmaceutical Co.,LtdNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGNov 17, 2022None givenDec 31, 2026
76617-003Hubei JXBio Pharmaceutical Co.,LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 9, 2025None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTApr 6, 2024None givenDec 31, 2026
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTOct 13, 2025None givenDec 31, 2026
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 28, 2024None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 28, 2024None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 12, 2025None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 28, 2024None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTSep 4, 2025None givenDec 31, 2026
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGFeb 5, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 6, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 6, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 6, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co. LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 7, 2026None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTApr 28, 2024None givenDec 31, 2026
14403-0024Hybio Pharmaceutical Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 17, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 18, 2026None givenDec 31, 2027
14403-0030Hybio Pharmaceutical Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 22, 2026None givenDec 31, 2027
14403-0030Hybio Pharmaceutical Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 22, 2026None givenDec 31, 2027
14403-0024Hybio Pharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 12, 2025None givenDec 31, 2026
14403-0030Hybio Pharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2026None givenDec 31, 2027
14403-0018Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJun 28, 2024None givenDec 31, 2026
85717-003Jilin Qijian Bio-Pharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTSep 14, 2026None givenDec 31, 2027
38779-3373Medisca Inc.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTApr 10, 2026None givenDec 31, 2027
69766-108MSN Life Sciences Private LimitedNot givenSemaglutidePOWDERNot given1 kg/kgBULK INGREDIENTSep 23, 2023None givenDec 31, 2026
84223-001NOMIDA LLCNot givenSemaglutidePOWDERNot given1 mg/mgBULK INGREDIENTApr 15, 2024May 15, 2027Not given
0420-9008Novo Nordisk A/SNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 6, 2017None givenDec 31, 2027
0420-9511Novo Nordisk A/SNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTNov 10, 2021None givenDec 31, 2027
82393-406Pharma Source Direct, Inc.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJul 1, 2024None givenDec 31, 2026
68067-2602PolyPeptide SANot givenSEMAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENTJun 1, 2020None givenDec 31, 2027
85207-019SCH Global Services Private LimitedNot givenSemaglutidePOWDERNot given100 g/100gBULK INGREDIENTAug 1, 2025None givenDec 31, 2026
41524-0012Shanghai Ambiopharm, IncNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 11, 2021None givenDec 31, 2027
84347-001Shenzhen Alvantis Pharma Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 23, 2024None givenDec 31, 2027
82920-505SHILPA PHARMA LIFESCIENCES LIMITEDNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 30, 2026None givenDec 31, 2027
85165-010Sichuan Jisheng Biopharmaceutical Co LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
76177-022Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTNov 1, 2023None givenDec 31, 2026
76177-054Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTMar 1, 2021None givenDec 31, 2026
76177-521Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 1, 2021None givenDec 31, 2027
61281-8700Supriya Lifescience LimitedNot givenSEMAGLUTIDEPOWDERNot given1 g/gBULK INGREDIENTSep 25, 2024None givenDec 31, 2026
29930-009Suzhou Lixin Pharmaceutical Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGNov 20, 2024None givenDec 31, 2026
87155-106Thaeta Scientific LLCNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 15, 2025None givenDec 31, 2027
85827-301Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 1, 2026None givenDec 31, 2026
85827-301Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 24, 2025None givenDec 31, 2026
85827-301Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 31, 2025None givenDec 31, 2026
85827-302Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 1, 2026None givenDec 31, 2026
85827-302Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 20, 2025None givenDec 31, 2026
85827-302Virtu Pharmako (Zhejiang) Co., Ltd.Not givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTDec 31, 2025None givenDec 31, 2026
65344-0041Zhejiang Jiuzhou Pharmaceutical Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTFeb 13, 2026None givenDec 31, 2027
84824-005Zhejiang Kingland Pharmaceutical Company LimitedNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 20, 2025None givenDec 31, 2026
84824-005Zhejiang Kingland Pharmaceutical Company LimitedNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-005Zhejiang Kingland Pharmaceutical Company LimitedNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-005Zhejiang Kingland Pharmaceutical Company LimitedNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-005Zhejiang Kingland Pharmaceutical Company LimitedNot givensemaglutidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
73569-035Zhejiang Peptites Biotech Co., LtdNot givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 26, 2022None givenDec 31, 2027
84643-101Zhejiang Tasln Biopharma Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENTNov 5, 2025None givenDec 31, 2026
84643-101Zhejiang Tasln Biopharma Co., Ltd.Not givenSemaglutidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGFeb 12, 2026None givenDec 31, 2027
87730-004Zhuhai Readline Biotech Co., Ltd.Not givenSemaglutidePOWDERNot given100 g/100gBULK INGREDIENTMay 27, 2026None givenDec 31, 2027
42973-383Apicore Pharmaceuticals Private LimitedNot givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTJun 11, 2024None givenDec 31, 2026
63415-0533Assia Chemical Industries Ltd. - Teva Tech SiteNot givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTMay 20, 2025None givenDec 31, 2026
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given50 g/50gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given10 g/10gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given25 mg/25mgBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given100 g/100gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given5 g/5gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given20 g/20gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given500 g/500gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJul 1, 2026None givenDec 31, 2027
16812-104Aurisco Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given200 g/200gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 16, 2024None givenDec 31, 2027
65727-109BIOCON LIMITEDNot givenTIRZEPATIDEPOWDERNot given1 kg/kgBULK INGREDIENTOct 22, 2025None givenDec 31, 2026
63474-700BioVectra Inc.Not givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTJan 27, 2025None givenDec 31, 2026
87181-003Chatnaa Life Sciences LLCNot givenTirzepatidePOWDERNot given1 mg/mgBULK INGREDIENTDec 30, 2025None givenDec 31, 2026
32861-0013Chengdu Shengnuo Biopharm Co., Ltd.Not givenTirzepatidePOWDERNot given100 g/100gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGNov 10, 2025None givenDec 31, 2027
32861-0013Chengdu Shengnuo Biopharm Co., Ltd.Not giventirzepatidePOWDERNot given100 g/100gBULK INGREDIENTApr 1, 2026None givenDec 31, 2027
84172-201Chongqing Sintaho Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTSep 1, 2026None givenDec 31, 2027
12869-210Corden Pharma Colorado, Inc.Not givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTMay 16, 2022None givenDec 31, 2026
71052-167DARMERICA, LLCNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTMay 2, 2023None givenDec 31, 2027
87370-008El-Peptido (Shanghai) Biopharmaceutical Co., LtdNot givenTIRZEPATIDEPOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJan 12, 2026None givenDec 31, 2027
0002-0770Eli Lilly and CompanyNot giventirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTJun 20, 2023None givenDec 31, 2026
84502-103Fujian Genohope Biotech Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJul 31, 2024None givenDec 31, 2027
85781-001Guangdong Longfu Medicine Co., Ltd.Not givenTIRZEPATIDEPOWDERNot given10 g/10gBULK INGREDIENTJun 9, 2025None givenDec 31, 2026
83783-001Hangzhou Hotide Biotech Co.,LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 1, 2025None givenDec 31, 2026
84385-104Harbin Jixianglong Biotech Co., Ltd.Not givenTirzepatidePOWDERNot given100 g/100gBULK INGREDIENTMay 9, 2025None givenDec 31, 2027
76617-020Hubei JXBio Pharmaceutical Co.,LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 5, 2022None givenDec 31, 2026
14403-0017Hybio Pharmaceutical Co. LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTMar 28, 2024None givenDec 31, 2026
14403-0029Hybio Pharmaceutical Co. LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGSep 16, 2026None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTApr 26, 2024None givenDec 31, 2026
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTApr 26, 2024None givenDec 31, 2026
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTApr 26, 2024None givenDec 31, 2026
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 26, 2024None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 26, 2024None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 26, 2024None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 26, 2024None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJun 26, 2024None givenDec 31, 2027
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTApr 1, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0027Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTOct 13, 2026None givenDec 31, 2027
14403-0028Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 23, 2026None givenDec 31, 2027
14403-0028Hybio Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 23, 2026None givenDec 31, 2027
14403-0017Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenTirzepatidePOWDERNot given1 mg/mgBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
14403-0020Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJun 26, 2024None givenDec 31, 2026
38779-3372Medisca Inc.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTApr 10, 2026None givenDec 31, 2027
69766-122MSN Life Sciences Private LimitedNot givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENTFeb 7, 2026None givenDec 31, 2027
84223-002Nomida LLCNot givenTirzepatidePOWDERNot given1 mg/mgBULK INGREDIENTApr 15, 2024May 15, 2027Not given
82393-407Pharma Source Direct, Inc.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJul 1, 2024None givenDec 31, 2026
24538-599Shanghai SynTheAll Pharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 kg/kgBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGApr 1, 2025None givenDec 31, 2027
84347-002Shenzhen Alvantis Pharma Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMay 23, 2024None givenDec 31, 2026
85165-012Sichuan Jisheng Biopharmaceutical Co LtdNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
76177-192Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 10, 2023None givenDec 31, 2026
76177-192Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGJan 10, 2023None givenDec 31, 2027
76177-501Sinopep-Allsino Biopharmaceutical Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTNov 1, 2023None givenDec 31, 2026
29930-010Suzhou Lixin Pharmaceutical Co., Ltd.Not giventirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGNov 20, 2024None givenDec 31, 2026
67649-0014Suzhou Tianma Pharma Group Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTSep 28, 2026None givenDec 31, 2027
87155-105Thaeta Scientific LLCNot givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGOct 15, 2025None givenDec 31, 2027
84824-006Zhejiang Kingland Pharmaceutical Company LimitedNot giventirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-006Zhejiang Kingland Pharmaceutical Company LimitedNot giventirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-006Zhejiang Kingland Pharmaceutical Company LimitedNot giventirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-006Zhejiang Kingland Pharmaceutical Company LimitedNot giventirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2026
84824-006Zhejiang Kingland Pharmaceutical Company LimitedNot giventirzepatidePOWDERNot given1 g/gBULK INGREDIENTJan 21, 2025None givenDec 31, 2027
73569-050Zhejiang Peptites Biotech Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGDec 29, 2023None givenDec 31, 2027
84643-102Zhejiang Tasln Biopharma Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENTFeb 5, 2026None givenDec 31, 2026
84643-102Zhejiang Tasln Biopharma Co., Ltd.Not givenTirzepatidePOWDERNot given1 g/gBULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDINGMar 11, 2026None givenDec 31, 2027

Drug for further processing

61434-067Catalent Indiana, LLCNot givensemaglutideINJECTION, SOLUTIONNot given1.7 mg/.75mLDRUG FOR FURTHER PROCESSINGJul 22, 2024None givenDec 31, 2027
61434-068Catalent Indiana, LLCNot givensemaglutideINJECTION, SOLUTIONNot given2.4 mg/.75mLDRUG FOR FURTHER PROCESSINGJul 22, 2024None givenDec 31, 2027
0420-9237Novo Nordisk A/SNot givensemaglutideINJECTION, SOLUTIONNot given.68 mg/mLDRUG FOR FURTHER PROCESSINGDec 6, 2017None givenDec 31, 2026
0420-9300Novo Nordisk A/SNot givenSemaglutideINJECTION, SOLUTIONNot given.5 mg/.5mLDRUG FOR FURTHER PROCESSINGJun 2, 2017None givenDec 31, 2027
0420-9301Novo Nordisk A/SNot givenSemaglutideINJECTION, SOLUTIONNot given.25 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 7, 2026None givenDec 31, 2027
0420-9302Novo Nordisk A/SNot givenSemaglutideINJECTION, SOLUTIONNot given1 mg/.5mLDRUG FOR FURTHER PROCESSINGApr 28, 2026None givenDec 31, 2027
0420-9317Novo Nordisk A/SNot givenSemaglutideINJECTION, SOLUTIONNot given1.7 mg/.75mLDRUG FOR FURTHER PROCESSINGApr 28, 2026None givenDec 31, 2027
0420-9324Novo Nordisk A/SNot givenSemaglutideINJECTION, SOLUTIONNot given2.4 mg/.75mLDRUG FOR FURTHER PROCESSINGApr 28, 2026None givenDec 31, 2027
0420-9520Novo Nordisk A/SNot givenSemaglutide SNACTABLETNot given3 mg/1DRUG FOR FURTHER PROCESSINGSep 20, 2019None givenDec 31, 2027
0420-9530Novo Nordisk A/SNot givenSemaglutide SNACTABLETNot given7 mg/1DRUG FOR FURTHER PROCESSINGSep 20, 2019None givenDec 31, 2027
0420-9540Novo Nordisk A/SNot givenSemaglutide SNACTABLETNot given14 mg/1DRUG FOR FURTHER PROCESSINGSep 20, 2019None givenDec 31, 2027
0420-9600Novo Nordisk A/SNot givensemaglutideINJECTION, SOLUTIONNot given2.68 mg/mLDRUG FOR FURTHER PROCESSINGApr 29, 2026None givenDec 31, 2027
43835-0028Novo Nordisk Production Belgium SANot givensemaglutideINJECTION, SOLUTIONNot given.5 mg/mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
43835-0029Novo Nordisk Production Belgium SANot givensemaglutideINJECTION, SOLUTIONNot given1 mg/mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
43835-0030Novo Nordisk Production Belgium SANot givensemaglutideINJECTION, SOLUTIONNot given2 mg/mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
43835-0031Novo Nordisk Production Belgium SANot givensemaglutideINJECTION, SOLUTIONNot given1.7 mg/.75mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
43835-0032Novo Nordisk Production Belgium SANot givensemaglutideINJECTION, SOLUTIONNot given2.4 mg/.75mLDRUG FOR FURTHER PROCESSINGApr 14, 2022None givenDec 31, 2027
43835-0055Novo Nordisk Production Belgium SANot givenSemaglutideINJECTION, SOLUTIONNot given.5 mg/.5mLDRUG FOR FURTHER PROCESSINGJan 1, 2025None givenDec 31, 2027
43835-0056Novo Nordisk Production Belgium SANot givenSemaglutideINJECTION, SOLUTIONNot given1 mg/.5mLDRUG FOR FURTHER PROCESSINGJan 1, 2025None givenDec 31, 2027
43835-0057Novo Nordisk Production Belgium SANot givenSemaglutideINJECTION, SOLUTIONNot given2 mg/.5mLDRUG FOR FURTHER PROCESSINGJan 1, 2025None givenDec 31, 2027
43835-0058Novo Nordisk Production Belgium SANot givenSemaglutideINJECTION, SOLUTIONNot given2.27 mg/.75mLDRUG FOR FURTHER PROCESSINGJan 1, 2025None givenDec 31, 2027
43835-0059Novo Nordisk Production Belgium SANot givenSemaglutideINJECTION, SOLUTIONNot given3.2 mg/.75mLDRUG FOR FURTHER PROCESSINGJan 1, 2025None givenDec 31, 2027
63552-200Patheon Manufacturing Services LLCNot givensemaglutideINJECTION, SOLUTIONNot given.25 mg/.5mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
63552-201Patheon Manufacturing Services LLCNot givensemaglutideINJECTION, SOLUTIONNot given.5 mg/.5mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
63552-203Patheon Manufacturing Services LLCNot givensemaglutideINJECTION, SOLUTIONNot given1.7 mg/.75mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
63552-205Patheon Manufacturing Services LLCNot givensemaglutideINJECTION, SOLUTIONNot given1 mg/.5mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
63552-206Patheon Manufacturing Services LLCNot givensemaglutideINJECTION, SOLUTIONNot given2.4 mg/.75mLDRUG FOR FURTHER PROCESSINGJun 5, 2021None givenDec 31, 2027
43624-015BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given2.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-016BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-017BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given7.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-018BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given10 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-019BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given12.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-020BSP Pharmaceuticals SpANot giventirzepatideINJECTION, SOLUTIONNot given15 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 1, 2023None givenDec 31, 2026
43624-033BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given2.5 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
43624-034BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given5 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
43624-035BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given7.5 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
43624-036BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given10 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
43624-037BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given12.5 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
43624-038BSP Pharmaceuticals SpANot givenMultiple-Dose Tirzepatide InjectionINJECTION, SOLUTIONNot given15 mg/.6mLDRUG FOR FURTHER PROCESSINGNov 30, 2025None givenDec 31, 2026
54568-043Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 12, 2022None givenDec 31, 2026
54568-170Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given2.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 12, 2022None givenDec 31, 2026
54568-325Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given15 mg/.5mLDRUG FOR FURTHER PROCESSINGJul 13, 2023None givenDec 31, 2026
54568-341Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given15 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-342Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given12.5 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-343Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given10 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-344Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given7.5 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-345Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given5 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-346Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given2.5 mg/.6mLDRUG FOR FURTHER PROCESSINGFeb 6, 2024None givenDec 31, 2027
54568-460Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given12.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 12, 2022None givenDec 31, 2026
54568-471Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given10 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 12, 2022None givenDec 31, 2026
54568-837Eli Lilly Italia SPANot giventirzepatideINJECTION, SOLUTIONNot given7.5 mg/.5mLDRUG FOR FURTHER PROCESSINGJul 13, 2023None givenDec 31, 2026
83516-0241Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given2.5 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0242Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given5 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0243Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given7.5 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0244Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given10 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0245Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given12.5 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0246Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given15 mg/.5mLDRUG FOR FURTHER PROCESSINGDec 27, 2024None givenDec 31, 2027
83516-0247Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given2.5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0248Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0249Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given7.5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0250Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given10 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0251Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given12.5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0252Resilience US, LLCNot giventirzepatideINJECTION, SOLUTIONNot given15 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 15, 2024None givenDec 31, 2027
83516-0257Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given2.5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 6, 2025None givenDec 31, 2027
83516-0258Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 6, 2025None givenDec 31, 2027
83516-0259Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given7.5 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 6, 2025None givenDec 31, 2027
83516-0260Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given10 mg/.5mLDRUG FOR FURTHER PROCESSINGMay 6, 2025None givenDec 31, 2027
83516-0261Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given12.5 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 15, 2025None givenDec 31, 2027
83516-0262Resilience US, LLCNot givenTirzepatideINJECTION, SOLUTIONNot given15 mg/.5mLDRUG FOR FURTHER PROCESSINGAug 15, 2025None givenDec 31, 2027

Finished drugs under an NDA, ANDA or BLA

50090-2853
NDA022341
A-S Medication SolutionsVictozaliraglutideINJECTIONSUBCUTANEOUS6 mg/mLNDAJan 25, 2010None givenDec 31, 2026
50090-4257
NDA206321
A-S Medication SolutionsSaxendaliraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLNDADec 31, 2014None givenDec 31, 2026
50090-4503
NDA022341
A-S Medication SolutionsVictozaliraglutideINJECTIONSUBCUTANEOUS6 mg/mLNDAJan 25, 2010None givenDec 31, 2026
50090-7501
NDA022341
A-S Medication SolutionsLiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLNDA AUTHORIZED GENERICJun 24, 2024None givenDec 31, 2026
50090-8145
ANDA217590
A-S Medication SolutionsLIRAGLUTIDELIRAGLUTIDEINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAJan 22, 2026None givenDec 31, 2027
70377-094
ANDA215245
Biocon Pharma Inc.LiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLANDAApr 25, 2026None givenDec 31, 2027
70377-095
ANDA217063
Biocon Pharma Inc.LiraglutideliraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAMar 27, 2026None givenDec 31, 2027
69097-910
ANDA217234
Cipla USA Inc.liraglutideliraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAFeb 25, 2026None givenDec 31, 2027
69097-920
ANDA217590
Cipla USA Inc.LIRAGLUTIDELIRAGLUTIDEINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAJan 22, 2026None givenDec 31, 2027
0143-9144
ANDA215503
Hikma Pharmaceuticals USA Inc.LiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLANDADec 24, 2024None givenDec 31, 2027
14403-3400
ANDA215503
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)LiraglutideLiraglutideINJECTION, SOLUTIONSUBCUTANEOUS18 mg/3mLANDAJun 21, 2024None givenDec 31, 2026
14403-3400
ANDA215503
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)LiraglutideLiraglutideINJECTION, SOLUTIONSUBCUTANEOUS18 mg/3mLANDADec 24, 2024None givenDec 31, 2026
14403-3400
ANDA215503
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)LiraglutideLiraglutideINJECTION, SOLUTIONSUBCUTANEOUS18 mg/3mLANDADec 24, 2024None givenDec 31, 2026
70748-346
ANDA215421
Lupin Pharmaceuticals, Inc.LiraglutideLiraglutideINJECTIONSUBCUTANEOUS6 mg/mLANDAOct 2, 2025None givenDec 31, 2027
71288-563
ANDA218115
Meitheal Pharmaceuticals Inc.LiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLANDAApr 2, 2025None givenDec 31, 2027
72603-745
ANDA218115
NorthStar Rx LLCLiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLANDAMar 1, 2026None givenDec 31, 2027
0169-2911
BLA208583
Novo NordiskXultophy 100/3.6insulin degludec and liraglutideINJECTION, SOLUTIONSUBCUTANEOUS100 [iU]/mL; 3.6 mg/mLBLANov 21, 2016None givenDec 31, 2026
0169-4060
NDA022341
Novo NordiskVictozaliraglutideINJECTIONSUBCUTANEOUS6 mg/mLNDAJan 25, 2010None givenDec 31, 2026
0169-2800
NDA206321
Novo Nordisk Pharmaceutical Industries, LPSaxendaliraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLNDADec 31, 2014None givenDec 31, 2027
81607-018
ANDA217590
Orbicular Pharmaceutical Technologies Private LimitedLIRAGLUTIDELIRAGLUTIDEINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAJan 21, 2026None givenDec 31, 2027
81607-019
ANDA217234
Orbicular Pharmaceutical Technologies Private LimitedliraglutideliraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAFeb 26, 2026None givenDec 31, 2027
0480-3667
NDA022341
Teva Pharmaceuticals USA, Inc.LiraglutideliraglutideINJECTIONSUBCUTANEOUS6 mg/mLNDA AUTHORIZED GENERICJun 24, 2024None givenDec 31, 2027
0480-7250
ANDA214568
Teva Pharmaceuticals, Inc.LiraglutideLiraglutideINJECTION, SOLUTIONSUBCUTANEOUS6 mg/mLANDAAug 28, 2025Sep 30, 2027Not given
50090-5824
NDA215256
A-S Medication SolutionsWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS.25 mg/.5mLNDAJun 5, 2021None givenDec 31, 2026
50090-5949
NDA209637
A-S Medication SolutionsOzempicsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1.34 mg/mLNDASep 30, 2020None givenDec 31, 2026
50090-6051
NDA209637
A-S Medication SolutionsOZEMPICsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.68 mg/mLNDAApr 25, 2022None givenDec 31, 2026
50090-8027
NDA209637
A-S Medication SolutionsOzempicsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS.68 mg/mLNDAOct 7, 2022None givenDec 31, 2027
0169-1704
NDA213051
Novo Nordisk Pharmaceutical Industries, LPOZEMPICoral semaglutideTABLETORAL4 mg/1NDAApr 27, 2026None givenDec 31, 2027
0169-1709
NDA213051
Novo Nordisk Pharmaceutical Industries, LPOZEMPICoral semaglutideTABLETORAL9 mg/1NDAApr 27, 2026None givenDec 31, 2027
0169-1715
NDA213051
Novo Nordisk Pharmaceutical Industries, LPOZEMPICoral semaglutideTABLETORAL1.5 mg/1NDAApr 27, 2026None givenDec 31, 2027
0169-4130
NDA209637
Novo Nordisk Pharmaceutical Industries, LPOzempicsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1.34 mg/mLNDASep 30, 2020None givenDec 31, 2027
0169-4181
NDA209637
Novo Nordisk Pharmaceutical Industries, LPOzempicsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS.68 mg/mLNDAOct 7, 2022None givenDec 31, 2027
0169-4303
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSoral semaglutideTABLETORAL3 mg/1NDASep 20, 2019None givenDec 31, 2027
0169-4307
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSoral semaglutideTABLETORAL7 mg/1NDASep 20, 2019None givenDec 31, 2027
0169-4314
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSoral semaglutideTABLETORAL14 mg/1NDASep 20, 2019None givenDec 31, 2027
0169-4404
NDA218316
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideTABLETORAL4 mg/1NDAJan 6, 2026None givenDec 31, 2027
0169-4409
NDA218316
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideTABLETORAL9 mg/1NDAJan 6, 2026None givenDec 31, 2027
0169-4415
NDA218316
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideTABLETORAL1.5 mg/1NDAJan 6, 2026None givenDec 31, 2027
0169-4425
NDA218316
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideTABLETORAL25 mg/1NDAJan 6, 2026None givenDec 31, 2027
0169-4501
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1 mg/.5mLNDAJun 5, 2021None givenDec 31, 2027
0169-4505
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS.5 mg/.5mLNDAJun 5, 2021None givenDec 31, 2027
0169-4517
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS1.7 mg/.75mLNDAJun 5, 2021None givenDec 31, 2027
0169-4524
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.4 mg/.75mLNDAJun 5, 2021None givenDec 31, 2027
0169-4525
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS.25 mg/.5mLNDAJun 5, 2021None givenDec 31, 2027
0169-4572
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS7.2 mg/.75mLNDAJun 5, 2021None givenDec 31, 2027
0169-4772
NDA209637
Novo Nordisk Pharmaceutical Industries, LPOzempicsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS2.68 mg/mLNDAApr 25, 2022None givenDec 31, 2027
0169-4915
NDA215256
Novo Nordisk Pharmaceutical Industries, LPWEGOVYsemaglutideINJECTION, SOLUTIONSUBCUTANEOUS3.2 mg/mLNDAJun 5, 2021None givenDec 31, 2027
50090-8021
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
50090-8022
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
50090-8023
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS7.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
50090-8024
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
50090-8025
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
50090-8026
NDA215866
A-S Medication SolutionsMOUNJAROtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS15 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-0152
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-0243
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-1152
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-1214
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS7.5 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-1243
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-1340
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-1423
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-1457
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS15 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-1460
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-1471
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-1484
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS7.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-1495
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-1506
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/.5mLNDAMay 13, 2022None givenDec 31, 2027
0002-2002
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS15 mg/.5mLNDAMar 28, 2024None givenDec 31, 2027
0002-2214
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS7.5 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-2340
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-2423
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-2457
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS15 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-2460
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-2471
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS10 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-2484
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS7.5 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-2495
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS5 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-2506
NDA217806
Eli Lilly and CompanyZEPBOUNDtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS2.5 mg/.5mLNDANov 8, 2023None givenDec 31, 2027
0002-3002
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS15 mg/.5mLNDAJul 28, 2023None givenDec 31, 2027
0002-3411
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS25 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3422
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20.8 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3433
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS16.7 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3444
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3455
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS8.33 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3466
NDA215866
Eli Lilly and CompanyMounjaro KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS4.17 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3511
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS25 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3522
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20.8 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3533
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS16.7 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3544
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3555
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS8.33 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-3566
NDA217806
Eli Lilly and CompanyZepbound KwikPentirzepatideINJECTION, SOLUTIONSUBCUTANEOUS4.17 mg/mLNDAJan 20, 2026None givenDec 31, 2027
0002-4052
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS4.17 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-4103
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS8.33 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-4210
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-4304
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS16.7 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-4523
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20.8 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-4612
NDA215866
Eli Lilly and CompanyMounjarotirzepatideINJECTION, SOLUTIONSUBCUTANEOUS25 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6052
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS4.17 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6103
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS8.33 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6210
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS12.5 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6304
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS16.7 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6523
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS20.8 mg/mLNDAJan 7, 2026None givenDec 31, 2027
0002-6612
NDA217806
Eli Lilly and CompanyZepboundtirzepatideINJECTION, SOLUTIONSUBCUTANEOUS25 mg/mLNDAJan 7, 2026None givenDec 31, 2027

Listings FDA removed or excluded from the Directory

FDA’s excluded drugs file leaves the substance name blank on most rows, so its rows were matched by a tracked drug in any name field or by an application number that a tracked-drug listing in the finished or unfinished files carries; a row with blank names and no application number cannot be matched. 8 rows matched, all under NDA. No compounded, bulk or other non-application listing naming a tracked drug was found in the excluded file read Nov 15, 2026; that is a statement about this one FDA file, nothing more.

50090-5138
NDA209637
A-S Medication SolutionsOzempicNot givenNot givenNot givenNot givenNDA
Flag I: Inactivated by the FDA.
Dec 6, 2017None givenDec 31, 2022
50090-5139
NDA209637
A-S Medication SolutionsOzempicNot givenNot givenNot givenNot givenNDA
Flag I: Inactivated by the FDA.
Dec 6, 2017None givenDec 31, 2022
0169-4132
NDA209637
Novo Nordisk Pharmaceutical Industries, LPOzempicNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Dec 6, 2017Sep 30, 2025Sep 30, 2025
0169-4136
NDA209637
Novo Nordisk Pharmaceutical Industries, LPOzempicNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Dec 6, 2017Oct 31, 2023Oct 31, 2023
0169-4804
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Sep 20, 2019Mar 31, 2025Mar 31, 2025
0169-4809
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Sep 20, 2019Mar 31, 2025Mar 31, 2025
0169-4815
NDA213051
Novo Nordisk Pharmaceutical Industries, LPRYBELSUSNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Sep 20, 2019Mar 31, 2025Mar 31, 2025
70518-2143
NDA209637
REMEDYREPACK INC.OzempicNot givenNot givenNot givenNot givenNDA
Flag D: Discontinued by the firm.
Jun 11, 2019May 3, 2021May 3, 2021

Files read

FDA fileFile dateRows in fileGLP-1 listings kept
NDC database file (finished drugs) (product.txt)Nov 10, 2026116659101
NDC unfinished drugs database file (unfinished_product.txt)Nov 10, 202621666283
NDC compounded drugs database file (compounders_ndc_directory.txt)Sep 18, 2026483675
NDC database excluded drugs database file (Products_excluded.txt)Nov 10, 20262075118

The compounded file groups package rows into one listing per product NDC. As a cross-check, openFDA’s drug NDC endpoint reported 142 for semaglutide, 168 for tirzepatide, 62 for liraglutide, 11 for retatrutide, 1 for cagrilintide (finished and unfinished listings) on Nov 15, 2026. The compounded drugs file holds the product reports of outsourcing facilities that elected to assign NDCs, so a facility that compounds a drug without reporting an NDC for it does not appear there.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.